Mastodon

VitUmnus vitamin and mineral complex (Tablets) Instructions for Use

Marketing Authorization Holder

Kron, LLC (Russia)

Manufactured By

VTF, LLC (Russia)

Dosage Form

Bottle OTC Icon VitUmnus vitamin and mineral complex Tablets: 60 pcs.

Dosage Form, Packaging, and Product Composition

Tablets weighing 630 mg.

1 dose (2 tab.) % of consumption level
Retinyl acetate (vit. A) 0.9 mg 113%1,*
Alpha-Tocopherol Acetate (vit. E) 10.06 mg# 101%1,*
Colecalciferol (vit. D3) 5 mcg 100%1
Phytomenadione (vit. K1) 120 mcg 100%2
Ascorbic acid (vit. C) 90 mg 150%1,*
Thiamine hydrochloride (vit. B1) 1.5 mg 107%1,*
Riboflavin (vit. B2) 1.8 mg 113%1,*
Niacinamide (vit. B3/PP) 18 mg 100%1
Calcium pantothenate (vit. B5) 6 mg 100%1
Pyridoxine hydrochloride (vit. B6) 2 mg 100%1
Biotin nicotinamide (vit. B7) 50 mcg 100%1
Folic acid (vit. B9) 400 mcg 200%1,*
Cyanocobalamin (vit. B12) 3 mcg 300%1,*
Calcium 150 mg 15%1
Magnesium 60 mg 15%1
Iron 14 mg 100%1
Copper 1 mg 100%2
Zinc 15 mg 100%1
Manganese 2 mg 100%2
Iodine 150 mcg 100%1
Molybdenum 70 mcg 100%2
Selenium 76 mcg 109%1,*
Chromium 50 mcg 100%2
Ubiquinone (coenzyme Q10) 4.5 mg 15%2

# in terms of tocopherol equivalent.
1 % of the recommended daily intake level according to TR TS 022/2011 “Food products in terms of their labeling” (Appendix 2).
2 % of the adequate intake level according to “Unified sanitary-epidemiological and hygienic requirements for goods subject to sanitary-epidemiological surveillance (control)” (Appendix 5).
* does not exceed the upper permissible intake level according to “Unified sanitary-epidemiological and hygienic requirements for goods subject to sanitary-epidemiological surveillance (control)”.
Information on the nutritional value of the product is determined by calculation based on the average content of the biologically active substance (BAS) in the product.

Composition carrier (microcrystalline cellulose), calcium carbonate, magnesium oxide, Ascorbic acid, zinc citrate, Alpha-Tocopherol Acetate 50% (DL-Alpha-Tocopherol Acetate, modified starch, maltodextrin, silicon dioxide), carrier (hydroxypropyl methylcellulose), Niacinamide, anti-caking agent (talc), Iron electrolytic, carriers (maltodextrin, croscarmellose sodium), colorant (titanium dioxide), Calcium pantothenate, manganese sulfate, vitamin A acetate 500000 IU/g, anti-caking agents (amorphous silicon dioxide, magnesium stearate (magnesium salt of stearic acid)), carrier (fatty acids (stearic acid)), carriers (polyvinylpyrrolidone, sodium croscarmellose), Ubiquinone (coenzyme Q10), humectant (propylene glycol), copper citrate, Phytomenadione 5% (gum arabic, sucrose, Phytomenadione), Colecalciferol 100 IU/mg, Pyridoxine hydrochloride, Thiamine hydrochloride, Riboflavin, chromium aspartate, Folic acid, potassium iodate, sodium molybdate, sodium selenite, biotin, Cyanocobalamin.

vitamin A acetate 500000 IU/g (gelatin, corn starch, sucrose, vitamin A acetate, butylated hydroxytoluene)
Or vitamin A acetate 500000 IU/g (sucrose, gelatin, starch and aluminum octenyl succinate ester, vitamin A acetate, butylated hydroxytoluene, sodium aluminosilicate).
Colecalciferol 100 IU/mg (modified starch, sucrose, sodium ascorbate, medium-chain triglycerides, silicon dioxide, DL-alpha-tocopherol, Colecalciferol)
Or Colecalciferol 100 IU/mg (modified starch, sucrose, coconut oil, DL-alpha-tocopherol, silicon dioxide, Colecalciferol),
Or Colecalciferol 100 IU/mg (sucrose, gum arabic, corn starch, medium-chain triglycerides, tricalcium phosphate, Colecalciferol, DL-alpha-tocopherol).

Nutritional value (1 tab.): carbohydrates – 0.02 g.
Energy value (1 tab.): 0.34 kJ/0.08 kcal.

15 pcs. – blisters (4) – cardboard packs.

Therapeutic Category

Dietary supplement – additional source of vitamins, minerals and coenzyme Q10

Indications

  • For the correction of vitamin and mineral deficiencies in the body resulting from an unbalanced or inadequate diet.
  • To help meet increased nutritional needs during periods of high physical and mental stress, stress, and during the recovery period after illnesses.
  • As an additional source of essential micronutrients, including coenzyme Q10, to support overall metabolic processes and energy production at the cellular level.

The product is intended for use in adults as a dietary supplement to the main diet and is not a medicine. It is recommended to consult a healthcare professional before starting use to determine individual needs.

Contraindications

  • Individual intolerance to any of the components of the dietary supplement. Patients with known allergies to any vitamins, minerals, or excipients listed in the composition should avoid use.
  • Pregnancy and breastfeeding. Due to the high content of certain vitamins, such as vitamin A, which can have teratogenic effects in high doses, and the lack of specific safety data for this formulation, use during pregnancy and lactation is contraindicated unless explicitly recommended by a physician.
  • Severe renal impairment or end-stage renal disease. Impaired renal function can alter the excretion of minerals and electrolytes, potentially leading to accumulation and toxicity.
  • Hemochromatosis, Wilson’s disease, or other disorders of iron or copper metabolism. The supplement contains significant amounts of these minerals and could exacerbate these conditions.
  • Hypervitaminosis of vitamins A, D, or any other component of the complex.

This product is not intended for use in children. The presence of chronic diseases, especially those involving the liver, kidneys, or cardiovascular system, requires prior consultation with a doctor.

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

The recommended daily dose for adults is two tablets once daily with meals. The tablets should be swallowed whole with a sufficient amount of water (approximately 150-200 ml).

Do not chew the tablets. The duration of continuous use is one month. If necessary, the course may be repeated after a consultation with a healthcare provider. It is important to adhere to the recommended dosage, as exceeding it does not enhance the beneficial effect and may increase the risk of adverse reactions.

The timing of administration (e.g., morning or evening) is not critical, but consistency is recommended for better adherence. The supplement is best absorbed when taken with food.

Adverse Reactions

Adverse reactions to VitUmnus complex are generally rare and mild when taken at the recommended dosage. The most commonly reported reactions are related to the gastrointestinal tract due to the high mineral content.

These may include nausea, epigastric discomfort, constipation, or diarrhea. These symptoms are usually transient and often resolve with continued use or by taking the supplement with a larger meal.

Allergic reactions are possible in susceptible individuals and may manifest as skin rash, itching, urticaria, or redness. In very rare cases, more severe hypersensitivity reactions, including angioedema, may occur. Discontinue use immediately and seek medical attention if any signs of an allergic reaction appear.

Due to the presence of iron, a harmless darkening of the stool may be observed, which is not a cause for concern. High doses of certain B vitamins, such as riboflavin (B2), can cause a bright yellow discoloration of urine; this is a normal, pharmacologically inert effect and is not harmful.

Drug Interactions

The VitUmnus complex contains minerals and vitamins that can interact with certain medications, potentially altering their efficacy or safety.

Antibiotics (Tetracyclines, Fluoroquinolones): Calcium, magnesium, iron, and zinc can form insoluble complexes with these antibiotics in the gastrointestinal tract, significantly reducing their absorption. A minimum interval of 2-3 hours should be maintained between taking the antibiotic and the vitamin-mineral complex.

Thyroid Hormones (Levothyroxine): Calcium and iron can impair the absorption of levothyroxine. It is crucial to take thyroid medication at least 4 hours before or after taking VitUmnus.

Anticoagulants (Warfarin): Vitamin K (phytomenadione) contained in the complex can antagonize the effect of vitamin K antagonists like warfarin, potentially reducing its anticoagulant effect and increasing the risk of thrombosis. Patients on such therapy should use this supplement with extreme caution and only under strict medical supervision with frequent monitoring of INR (International Normalized Ratio).

Diuretics (Potassium-sparing, e.g., Spironolactone): The supplement contains potassium in trace amounts from its composition, but caution is advised when combined with potassium-sparing diuretics due to the potential risk of hyperkalemia, although the risk is considered low with this formulation.

Other Vitamin Supplements: Concurrent use of other products containing vitamins A, D, E, K, and minerals, especially iron, copper, and selenium, may lead to excessive accumulation and toxicity. The total intake from all sources should be considered.

Overdose

Acute overdose with VitUmnus is unlikely from taking a few extra tablets, but chronic intake of doses significantly exceeding the recommended amount can lead to hypervitaminosis and mineral toxicity.

Symptoms of acute overdose may include severe gastrointestinal distress (nausea, vomiting, abdominal pain, diarrhea), headache, dizziness, and lethargy. In cases of massive iron overdose, which is particularly dangerous, symptoms can progress to metabolic acidosis, hepatic necrosis, and cardiovascular collapse.

Symptoms of chronic overdose are specific to the accumulated substance: Vitamin A hypervitaminosis can cause dry skin, pruritus, alopecia, increased intracranial pressure, and hepatotoxicity. Vitamin D hypervitaminosis can lead to hypercalcemia, manifested by weakness, fatigue, nausea, vomiting, and renal calcification.

In case of suspected overdose, immediately discontinue the supplement and seek medical attention or contact a poison control center. Treatment is symptomatic and supportive. Gastric lavage or administration of activated charcoal may be considered if ingestion was recent. Specific antidotes, such as deferoxamine for iron poisoning, may be used in a hospital setting.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS